Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials

Website_Image_ERSO__David_Shapiro__Paul_Hergenrother_(1).png
Estrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75 percent of breast cancer patients. In advanced and metastatic form, it is lethal, claiming the lives of nearly 350,000 individuals annually. Presently, no drug is able to eradicate these...

CAR-T immune therapy attacks ovarian cancer in mice with a single dose

Researchers from the University of Illinois Urbana-Champaign who worked on a CAR-T immune therapy gather in a lab for a photo. Pictured, from front left: postdoctoral researcher Diana Rose Ranoa, graduate student Claire Schane, professor emeritus of biochemistry David Kranz (front center), researcher Amber Lewis and professor emeritus of pathology Edward Roy.
CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests. The researchers successfully deployed CAR-T in a mouse model of ovarian cancer, a type of aggressive, solid-tumor...

Researchers demonstrate new cancer drug development method

Emad Tajkhorshid poses by journal covers
Researchers from the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign and the University of Illinois Chicago collaborated to highlight lipid-protein interaction as a new avenue for oncology drug development.

New faculty members begin teaching and research at U of I

Roughly a dozen new faculty members in the College of LAS stand together for a group photo indoors.
The College of LAS is welcoming 38 new professors for the 2022-23 academic year. Their new positions range from clinical professors to assistant professors and an endowed position in more than 20 academic units, ranging from African American studies to economics, philosophy, statistics, and several...

Cancer Center at Illinois announces 2022 cancer research grant recipients

Image of sign on wall that says "Cancer Center at Illinois" with Block I logo above it.
The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer research projects, involving multiple MCB faculty members, designed by University of Illinois Urbana-Champaign faculty to be funded by Cancer Center at Illinois (CCIL) developmental grant awards.

New therapeutic target identified for triple-negative breast cancer

Gloved hands working with a pipette. Person's face can't be seen. They are in a lab coat and the background is a lab.
Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have...